Pearls

Helping patients quit smoking: Lessons from the EAGLES trial

Author and Disclosure Information

 

References

When it comes time to select a medication regimen, for bupropion, consider starting the patient with 150 mg/d, and increasing the dose to 150 mg twice a day 4 days later. The target quit date should be 7 days after starting the medication. Monitor the patient for symptoms of anxiety and insomnia.

For varenicline, start the patient at 0.5 mg/d, and increase the dose to 0.5 mg twice a day 4 days later. After another 4 days, increase the dose to 1 mg twice a day. Set a target quit date for 7 days after starting medication. Monitor the patient for nausea, insomnia, and abnormal dreams.

Pages

Recommended Reading

E-cigarette usage has changed
MDedge Psychiatry
Subcutaneous buprenorpine rivals sublingual for opioid use disorder
MDedge Psychiatry
FDA queries more companies about youth e-cig use
MDedge Psychiatry
Legalization of marijuana debate moving away from medical need
MDedge Psychiatry
Drug-related deaths continue to rise in United States
MDedge Psychiatry
VIDEO: Pills alone not the answer for pain management
MDedge Psychiatry
Alcohol abuse untreated in HCV patients, including HIV coinfected
MDedge Psychiatry
SAMHSA’s new general embarks on a new mission
MDedge Psychiatry
Hefty rewards pay off in smoking-cessation study
MDedge Psychiatry
Link between alcohol consumption, neuroinflammation has possible treatment implications
MDedge Psychiatry